Cell therapy weekly: US FDA grants expanded access to Zofin™ for the treatment of COVID-19

Written by RegMedNet

This week: the US FDA has granted expanded access for Zofin™ to treat COVID-19 patients, a new patent has been issued for the delivery of cardiac cell therapy through arteries in the wrist, cellnest® for optimal adhesion and proliferation of stem cells is now exclusively distributed by FUJIFILM Irvine Scientific, and Orgenesis acquires Koligo Therapeutics and obtains their COVID-19 cell therapy. The news highlights: US FDA grants expanded access to Zofin™ for the treatment of COVID-19 New patent issued for delivery of cardiac cell therapy through the wrist Cellnest® substrate for optimal adhesion and proliferation of stem cells to be...

To view this content, please register now for access

It's completely free